Total Funding
93
70
Total FundingSeries D raised
Growth Score
-2 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
21662
ABK Biomedical combines the clinical market with biomaterials with a focus on treating hypervascular tumors.
Daniel Boyd: Co-Founder- Michael Mangano: President and CEOPast Role: ReShape Medical, President and CEO
About the Company
ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors.
The company is dedicated to transforming an interventional radiology procedure called embolization.
